Sector : Pharmaceuticals
BSE
108.30 -0.51%
NSE
108.50 -0.37 %
Oct 30, 13:23
Hikal Q2 faced multiple headwinds, top line set to get back mojo in FY21
Oct 25, 22:24
Oct 10, 13:33
Ideas for Profit | Hikal’s exposure to promising markets makes it an attractive stock
Aug 01, 16:05
Hikal Standalone June 2019 Net Sales at Rs 403.16 crore, up 23.82% Y-o-Y
Nov 22, 10:04
Dec 06, 16:00
Price
BSE
108.30 -0.51%
NSE
108.50 -0.37%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
